Related Experiment Videos
Prevalence of sleep disordered breathing in a heart failure program
Robin J Trupp1, Peggy Hardesty, Julia Osborne
1Davis Heart and Lung Research Institute, Ohio State University, 473 W. 12th Avenue, Columbus, OH 43210-1252, USA. rjtrupp@tmo.blackberry.net.
Congestive Heart Failure (Greenwich, Conn.)
|October 8, 2004
Summary
Sleep-disordered breathing (SDB) affects 42% of stable heart failure patients, even with optimal care. Early screening and treatment, like continuous positive airway pressure, can improve outcomes for these patients.
Area of Science:
- Cardiology
- Sleep Medicine
- Pulmonology
Background:
- Sleep-disordered breathing (SDB) is increasingly recognized as a significant comorbidity in heart failure (HF).
- SDB contributes to increased morbidity and mortality in patients with HF, particularly those with systolic left ventricular dysfunction.
Purpose of the Study:
- To determine the prevalence of SDB in stable heart failure patients, irrespective of ejection fraction.
- To assess the utility of outpatient screening for SDB in a heart failure clinic setting.
Main Methods:
- A prospective screening study was conducted in a heart failure clinic over three consecutive days.
- Patients underwent outpatient screening for SDB using a device collecting thoracic impedance, oxyhemoglobin saturation, and ECG data.
- Patients with moderate to severe SDB were referred for polysomnography and continuous positive airway pressure (CPAP) therapy confirmation.
Main Results:
- 42% of stable heart failure patients screened positive for moderate to severe SDB.
- 55% had mild or no significant SDB.
- 14 out of 16 patients with moderate to severe SDB received subsequent treatment via CPAP therapy.
Conclusions:
- A high prevalence of SDB exists in stable heart failure patients, even when receiving optimal medical care.
- Outpatient screening for SDB is feasible and identifies a significant number of HF patients requiring further evaluation and treatment.
- Addressing SDB through therapies like CPAP may be crucial for managing heart failure outcomes.